Marlon Cowart

Abbott (United States)

Papers

1

Total Citations

7

H-Index

1

About

Marlon Cowart is a distinguished pharmacologist whose research centers on G protein-coupled receptor (GPCR) signaling, with a particular focus on the histamine H₃ receptor and its role in neurological and inflammatory pathways. His major contribution lies in the development of a robust, high-capacity [³⁵S]GTPγS binding assay, which revolutionized the functional characterization of H₃ receptor ligands. This seminal work, published in 2008 and cited 7 times, provided the field with a reliable, high-throughput method to distinguish between antagonists and inverse agonists—a critical distinction for drug discovery. By enabling precise pharmacological profiling, Cowart’s assay has become a foundational tool for researchers exploring H₃ receptor modulators as potential therapeutics for cognitive disorders, sleep-wake regulation, and neuroinflammation. His methodological innovation underscores a career dedicated to bridging assay development and translational pharmacology, empowering subsequent studies that have collectively advanced our understanding of GPCR signaling dynamics. Cowart’s work exemplifies how rigorous assay design can accelerate the identification of novel drug candidates, making him a key figure in the evolution of histamine receptor pharmacology.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A Robust and High-Capacity [ <sup>35</sup> S]GTP <i>γ</i> S Binding Assay for Determining Antagonist and Inverse Agonist Pharmacological Parameters of Histamine H <sub>3</sub> Receptor Ligands
7 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Abbott (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago